$ADMS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adamas Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adamas Pharmaceuticals Inc. Get notifications about new insider transactions in Adamas Pharmaceuticals Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 07 2016 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | J | 0.00 | 117,450 | 0 | 146,208 | 263.7 K to 146.2 K (-44.55 %) |
| Sep 22 2016 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 18.09 | 30,000 | 542,700 | 30,000 | |
| Sep 16 2016 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Buy | P | 16.81 | 8,240 | 138,497 | 4,031,804 | 4 M to 4 M (+0.20 %) |
| Sep 16 2016 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Buy | P | 16.50 | 200 | 3,300 | 4,023,564 | 4 M to 4 M (0.00 %) |
| Sep 16 2016 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Buy | P | 16.43 | 54,537 | 895,787 | 4,023,364 | 4 M to 4 M (+1.37 %) |
| Sep 16 2016 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Buy | P | 16.81 | 8,240 | 138,497 | 4,031,804 | 4 M to 4 M (+0.20 %) |
| Sep 16 2016 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Buy | P | 16.50 | 200 | 3,300 | 4,023,564 | 4 M to 4 M (0.00 %) |
| Sep 16 2016 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Buy | P | 16.43 | 54,537 | 895,787 | 4,023,364 | 4 M to 4 M (+1.37 %) |
| Sep 14 2016 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Buy | P | 15.56 | 62,034 | 964,995 | 3,968,827 | 3.9 M to 4 M (+1.59 %) |
| Sep 14 2016 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Buy | P | 15.65 | 22,342 | 349,735 | 3,906,793 | 3.9 M to 3.9 M (+0.58 %) |
| Sep 14 2016 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Buy | P | 15.56 | 62,034 | 964,995 | 3,968,827 | 3.9 M to 4 M (+1.59 %) |
| Sep 14 2016 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Buy | P | 15.65 | 22,342 | 349,735 | 3,906,793 | 3.9 M to 3.9 M (+0.58 %) |
| Sep 09 2016 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Buy | P | 15.68 | 60,846 | 954,065 | 3,884,451 | 3.8 M to 3.9 M (+1.59 %) |
| Sep 09 2016 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Buy | P | 15.68 | 60,846 | 954,065 | 3,884,451 | 3.8 M to 3.9 M (+1.59 %) |
| Sep 07 2016 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Buy | P | 15.00 | 7,200 | 107,980 | 3,823,605 | 3.8 M to 3.8 M (+0.19 %) |
| Sep 07 2016 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Buy | P | 14.75 | 43,719 | 644,921 | 3,816,405 | 3.8 M to 3.8 M (+1.16 %) |
| Sep 07 2016 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Buy | P | 15.00 | 7,200 | 107,980 | 3,823,605 | 3.8 M to 3.8 M (+0.19 %) |
| Sep 07 2016 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Buy | P | 14.75 | 43,719 | 644,921 | 3,816,405 | 3.8 M to 3.8 M (+1.16 %) |
| Aug 08 2016 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 13.68 | 12,600 | 172,368 | 12,600 | |
| Jun 16 2016 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 204,900 | 384,188 | 0 | |
| Jun 16 2016 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 204,900 | 384,188 | 263,658 | 58.8 K to 263.7 K (+348.72 %) |
| Jun 07 2016 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 17.03 | 15,000 | 255,450 | 15,000 | |
| Jun 07 2016 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 17.03 | 15,000 | 255,450 | 15,000 | |
| Jun 07 2016 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Option Exercise | A | 17.03 | 15,000 | 255,450 | 15,000 | |
| Jun 07 2016 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Option Exercise | A | 17.03 | 15,000 | 255,450 | 15,000 | |
| Jun 07 2016 | ADMS | Adamas Pharmaceuti ... | DEMSKI MARTHA J | Director | Option Exercise | A | 17.03 | 15,000 | 255,450 | 15,000 | |
| Jun 07 2016 | ADMS | Adamas Pharmaceuti ... | BOOTH RICHARD H | Director | Option Exercise | A | 17.03 | 15,000 | 255,450 | 15,000 | |
| May 23 2016 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | General Counsel | Option Exercise | A | 14.70 | 67,500 | 992,250 | 67,500 | |
| May 23 2016 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | General Counsel | Grant | A | 0.00 | 11,250 | 0 | 11,250 | 0 to 11.3 K |
| Mar 08 2016 | ADMS | Adamas Pharmaceuti ... | DAWSON WILLIAM J | Chief Financial Off ... | Option Exercise | A | 13.66 | 45,000 | 614,700 | 45,000 | |
| Mar 08 2016 | ADMS | Adamas Pharmaceuti ... | DAWSON WILLIAM J | Chief Financial Off ... | Grant | A | 13.66 | 7,500 | 102,450 | 7,500 | 0 to 7.5 K |
| Mar 08 2016 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | A | 13.66 | 172,500 | 2,356,350 | 172,500 | |
| Mar 08 2016 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Grant | A | 13.66 | 28,750 | 392,725 | 58,758 | 30 K to 58.8 K (+95.81 %) |
| Mar 08 2016 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Option Exercise | A | 13.66 | 45,000 | 614,700 | 45,000 | |
| Mar 08 2016 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Grant | A | 13.66 | 7,500 | 102,450 | 8,340 | 840 to 8.3 K (+892.86 %) |
| Mar 08 2016 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Option Exercise | A | 13.66 | 45,000 | 614,700 | 45,000 | |
| Mar 08 2016 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Grant | A | 13.66 | 7,500 | 102,450 | 7,500 | 0 to 7.5 K |
| Apr 20 2016 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Option Exercise | M | 0.67 | 23,334 | 15,517 | 16,666 | |
| Apr 20 2016 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Option Exercise | M | 1.76 | 12,666 | 22,229 | 0 | |
| Apr 20 2016 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Sell | S | 18.50 | 23,334 | 431,679 | 8,340 | 31.7 K to 8.3 K (-73.67 %) |
| Apr 20 2016 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Buy | M | 0.67 | 23,334 | 15,517 | 31,674 | 8.3 K to 31.7 K (+279.78 %) |
| Apr 20 2016 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Sell | S | 18.50 | 12,666 | 234,321 | 8,340 | 21 K to 8.3 K (-60.30 %) |
| Apr 20 2016 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Buy | M | 1.76 | 12,666 | 22,229 | 21,006 | 8.3 K to 21 K (+151.87 %) |
| Dec 09 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Sell | S | 16.23 | 3,000 | 48,690 | 48,000 | 51 K to 48 K (-5.88 %) |
| Nov 04 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Sell | S | 15.00 | 3,000 | 45,000 | 51,000 | 54 K to 51 K (-5.56 %) |
| Oct 07 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Sell | S | 16.75 | 3,000 | 50,250 | 54,000 | 57 K to 54 K (-5.26 %) |
| Sep 10 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Sell | S | 19.13 | 3,000 | 57,390 | 57,000 | 60 K to 57 K (-5.00 %) |
| Aug 05 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Sell | S | 24.51 | 3,000 | 73,530 | 60,000 | 63 K to 60 K (-4.76 %) |
| Jul 14 2015 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Sell | S | 27.53 | 8,657 | 238,308 | 287,992 | 296.6 K to 288 K (-2.92 %) |
| Jul 14 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Sell | S | 27.53 | 8,657 | 238,308 | 287,992 | 296.6 K to 288 K (-2.92 %) |
| Jul 09 2015 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Sell | S | 27.55 | 3,100 | 85,408 | 296,649 | 299.7 K to 296.6 K (-1.03 %) |
| Jul 09 2015 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Sell | S | 27.55 | 25,737 | 708,931 | 299,749 | 325.5 K to 299.7 K (-7.91 %) |
| Jul 09 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Sell | S | 27.55 | 3,100 | 85,408 | 296,649 | 299.7 K to 296.6 K (-1.03 %) |
| Jul 09 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Sell | S | 27.55 | 25,737 | 708,931 | 299,749 | 325.5 K to 299.7 K (-7.91 %) |
| Jul 08 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Sell | S | 25.91 | 3,000 | 77,730 | 63,000 | 66 K to 63 K (-4.55 %) |
| Jun 22 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Sell | S | 27.54 | 15,842 | 436,251 | 325,486 | 341.3 K to 325.5 K (-4.64 %) |
| Jun 22 2015 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Sell | S | 27.54 | 15,842 | 436,251 | 325,486 | 341.3 K to 325.5 K (-4.64 %) |
| Jun 17 2015 | ADMS | Adamas Pharmaceuti ... | BOOTH RICHARD H | Director | Sell | S | 19.32 | 1,000 | 19,320 | 45,778 | 46.8 K to 45.8 K (-2.14 %) |
| Jun 09 2015 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Option Exercise | A | 19.14 | 120,000 | 2,296,800 | 120,000 | |
| Jun 09 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Option Exercise | M | 1.76 | 2,000 | 3,510 | 12,666 | |
| Jun 09 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Sell | S | 18.95 | 2,000 | 37,900 | 840 | 2.8 K to 840 (-70.42 %) |
| Jun 09 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Buy | M | 1.76 | 2,000 | 3,510 | 2,840 | 840 to 2.8 K (+238.10 %) |
| Jun 03 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Sell | S | 17.93 | 3,000 | 53,790 | 66,000 | 69 K to 66 K (-4.35 %) |
| Jun 01 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Sell | S | 18.02 | 112,073 | 2,019,555 | 341,328 | 453.4 K to 341.3 K (-24.72 %) |
| Jun 01 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Sell | S | 18.02 | 7,483 | 134,821 | 453,401 | 460.9 K to 453.4 K (-1.62 %) |
| Jun 01 2015 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Sell | S | 18.02 | 112,073 | 2,019,555 | 341,328 | 453.4 K to 341.3 K (-24.72 %) |
| Jun 01 2015 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Sell | S | 18.02 | 7,483 | 134,821 | 453,401 | 460.9 K to 453.4 K (-1.62 %) |
| May 20 2015 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Sell | S | 18.04 | 1,643 | 29,640 | 460,884 | 462.5 K to 460.9 K (-0.36 %) |
| May 20 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Sell | S | 18.04 | 1,643 | 29,640 | 460,884 | 462.5 K to 460.9 K (-0.36 %) |
| May 18 2015 | ADMS | Adamas Pharmaceuti ... | BOOTH RICHARD H | Director | Option Exercise | A | 17.97 | 19,000 | 341,430 | 19,000 | |
| May 18 2015 | ADMS | Adamas Pharmaceuti ... | BOOTH RICHARD H | Director | Sell | S | 17.85 | 1,000 | 17,850 | 46,778 | 47.8 K to 46.8 K (-2.09 %) |
| May 18 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Option Exercise | A | 17.97 | 19,000 | 341,430 | 19,000 | |
| May 18 2015 | ADMS | Adamas Pharmaceuti ... | Lewis Sara Grootwassink | Director | Option Exercise | A | 17.97 | 18,000 | 323,460 | 18,000 | |
| May 18 2015 | ADMS | Adamas Pharmaceuti ... | DEMSKI MARTHA J | Director | Option Exercise | A | 17.97 | 18,000 | 323,460 | 18,000 | |
| May 18 2015 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 17.97 | 21,000 | 377,370 | 21,000 | |
| May 18 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Option Exercise | A | 17.97 | 19,000 | 341,430 | 19,000 | |
| May 18 2015 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 17.97 | 19,000 | 341,430 | 19,000 | |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 100 | 188 | 214,900 | |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 10,028 | 18,803 | 215,000 | |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 500 | 938 | 225,028 | |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 200 | 3,600 | 390,792 | 391 K to 390.8 K (-0.05 %) |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 100 | 1,800 | 30,008 | 30.1 K to 30 K (-0.33 %) |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 100 | 188 | 30,108 | 30 K to 30.1 K (+0.33 %) |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 100 | 1,800 | 390,992 | 391.1 K to 391 K (-0.03 %) |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 28 | 504 | 30,008 | 30 K to 30 K (-0.09 %) |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 10,028 | 18,803 | 30,036 | 20 K to 30 K (+50.12 %) |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 1,800 | 32,400 | 391,092 | 392.9 K to 391.1 K (-0.46 %) |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.01 | 500 | 9,003 | 20,008 | 20.5 K to 20 K (-2.44 %) |
| May 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 500 | 938 | 20,508 | 20 K to 20.5 K (+2.50 %) |
| May 07 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Option Exercise | M | 1.76 | 2,000 | 3,510 | 14,666 | |
| May 07 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Sell | S | 17.62 | 2,000 | 35,240 | 840 | 2.8 K to 840 (-70.42 %) |
| May 07 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Buy | M | 1.76 | 2,000 | 3,510 | 2,840 | 840 to 2.8 K (+238.10 %) |
| May 06 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Sell | S | 16.82 | 3,000 | 50,460 | 69,000 | 72 K to 69 K (-4.17 %) |
| Apr 27 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 900 | 1,688 | 225,528 | |
| Apr 27 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.01 | 2,400 | 43,212 | 392,892 | 395.3 K to 392.9 K (-0.61 %) |
| Apr 27 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 900 | 16,200 | 20,008 | 20.9 K to 20 K (-4.30 %) |
| Apr 27 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 900 | 1,688 | 20,908 | 20 K to 20.9 K (+4.50 %) |
| Apr 22 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 962 | 1,804 | 226,428 | |
| Apr 22 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 2,610 | 4,894 | 227,390 | |
| Apr 22 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 1,811 | 32,602 | 395,292 | 397.1 K to 395.3 K (-0.46 %) |
| Apr 22 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.01 | 962 | 17,322 | 20,008 | 21 K to 20 K (-4.59 %) |
| Apr 22 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 962 | 1,804 | 20,970 | 20 K to 21 K (+4.81 %) |
| Apr 22 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 5,200 | 93,601 | 397,103 | 402.3 K to 397.1 K (-1.29 %) |
| Apr 22 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 2,610 | 46,981 | 20,008 | 22.6 K to 20 K (-11.54 %) |
| Apr 22 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 2,610 | 4,894 | 22,618 | 20 K to 22.6 K (+13.04 %) |
| Apr 16 2015 | ADMS | Adamas Pharmaceuti ... | BOOTH RICHARD H | Director | Sell | S | 17.72 | 1,000 | 17,720 | 47,778 | 48.8 K to 47.8 K (-2.05 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Sell | S | 18.56 | 37,078 | 688,056 | 462,527 | 499.6 K to 462.5 K (-7.42 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Sell | S | 18.56 | 37,078 | 688,056 | 462,527 | 499.6 K to 462.5 K (-7.42 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 10,000 | 18,750 | 220,000 | |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 80 | 150 | 230,000 | |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 1,000 | 1,875 | 230,080 | |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 100 | 1,800 | 402,303 | 402.4 K to 402.3 K (-0.02 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | S | 1.88 | 10,000 | 18,750 | 20,008 | 10 K to 20 K (+99.92 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 80 | 1,440 | 10,008 | 10.1 K to 10 K (-0.79 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 80 | 150 | 10,088 | 10 K to 10.1 K (+0.80 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 19.07 | 500 | 9,535 | 402,403 | 402.9 K to 402.4 K (-0.12 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.16 | 3,077 | 55,877 | 402,903 | 406 K to 402.9 K (-0.76 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 19.00 | 100 | 1,900 | 10,008 | 10.1 K to 10 K (-0.99 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.09 | 900 | 16,280 | 10,108 | 11 K to 10.1 K (-8.18 %) |
| Apr 14 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 1,000 | 1,875 | 11,008 | 10 K to 11 K (+9.99 %) |
| Apr 07 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Option Exercise | M | 1.76 | 2,000 | 3,510 | 16,666 | |
| Apr 07 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Sell | S | 17.44 | 2,000 | 34,880 | 840 | 2.8 K to 840 (-70.42 %) |
| Apr 07 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Buy | M | 1.76 | 2,000 | 3,510 | 2,840 | 840 to 2.8 K (+238.10 %) |
| Apr 07 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Sell | S | 17.44 | 3,000 | 52,320 | 72,000 | 75 K to 72 K (-4.00 %) |
| Mar 24 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 100 | 188 | 231,080 | |
| Mar 24 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 200 | 3,600 | 405,980 | 406.2 K to 406 K (-0.05 %) |
| Mar 24 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 100 | 1,800 | 10,008 | 10.1 K to 10 K (-0.99 %) |
| Mar 24 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 100 | 188 | 10,108 | 10 K to 10.1 K (+1.00 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Sell | S | 18.04 | 7,200 | 129,893 | 499,605 | 506.8 K to 499.6 K (-1.42 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | MDV IX LP | 10% Owner | Sell | S | 18.00 | 4,523 | 81,414 | 506,805 | 511.3 K to 506.8 K (-0.88 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Sell | S | 18.04 | 7,200 | 129,893 | 499,605 | 506.8 K to 499.6 K (-1.42 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Sell | S | 18.00 | 4,523 | 81,414 | 506,805 | 511.3 K to 506.8 K (-0.88 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 12,320 | 23,100 | 231,180 | |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 4,600 | 8,625 | 243,500 | |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | M | 1.88 | 1,900 | 3,563 | 248,100 | |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 2,148 | 38,664 | 406,180 | 408.3 K to 406.2 K (-0.53 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 2,320 | 41,760 | 10,008 | 12.3 K to 10 K (-18.82 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 12,320 | 23,100 | 12,328 | 8 to 12.3 K (+154,000.00 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 9,420 | 169,602 | 408,328 | 417.7 K to 408.3 K (-2.25 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 4,600 | 82,803 | 8 | 4.6 K to 8 (-99.83 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 4,600 | 8,625 | 4,608 | 8 to 4.6 K (+57,500.00 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 2,700 | 48,600 | 417,748 | 420.4 K to 417.7 K (-0.64 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 18.00 | 1,900 | 34,200 | 8 | 1.9 K to 8 (-99.58 %) |
| Mar 19 2015 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | M | 1.88 | 1,900 | 3,563 | 1,908 | 8 to 1.9 K (+23,750.00 %) |
| Mar 17 2015 | ADMS | Adamas Pharmaceuti ... | BOOTH RICHARD H | Director | Sell | S | 17.36 | 1,000 | 17,360 | 48,778 | 49.8 K to 48.8 K (-2.01 %) |
| Mar 17 2015 | ADMS | Adamas Pharmaceuti ... | aeris Capital Equity Investmen ... | 10% Owner | Sell | S | 17.23 | 350,000 | 6,030,500 | 1,662,128 | 2 M to 1.7 M (-17.39 %) |
| Mar 09 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Option Exercise | M | 1.76 | 2,000 | 3,510 | 18,666 | |
| Mar 09 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Sell | S | 17.15 | 2,000 | 34,300 | 840 | 2.8 K to 840 (-70.42 %) |
| Mar 09 2015 | ADMS | Adamas Pharmaceuti ... | McClure Natalie | SVP, Product Develo ... | Buy | M | 1.76 | 2,000 | 3,510 | 2,840 | 840 to 2.8 K (+238.10 %) |
| Mar 04 2015 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Sell | S | 16.97 | 3,000 | 50,910 | 75,000 | 78 K to 75 K (-3.85 %) |